These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 25595540

  • 21. Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue.
    Dueholm Hjorth IM, Kristensen SG, Dueholm M, Humaidan P.
    Fertil Steril; 2020 Aug; 114(2):379-387. PubMed ID: 32624219
    [Abstract] [Full Text] [Related]

  • 22. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
    Das M, Shehata F, Son WY, Tulandi T, Holzer H.
    Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
    [Abstract] [Full Text] [Related]

  • 23. Efficiency of oocyte cryopreservation: a meta-analysis.
    Oktay K, Cil AP, Bang H.
    Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
    [Abstract] [Full Text] [Related]

  • 24. Ovarian Response and in Vitro Fertilization Outcomes After Salpingectomy: Does Salpingectomy Indication Matter?
    Pereira N, Pryor KP, Voskuilen-Gonzalez A, Lekovich JP, Elias RT, Spandorfer SD, Rosenwaks Z.
    J Minim Invasive Gynecol; 2017 Jul; 24(3):446-454.e1. PubMed ID: 28069482
    [Abstract] [Full Text] [Related]

  • 25. Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review.
    Alvarez M, Solé M, Devesa M, Fábregas R, Boada M, Tur R, Coroleu B, Veiga A, Barri PN.
    Reprod Biomed Online; 2014 Jun; 28(6):663-8. PubMed ID: 24745835
    [Abstract] [Full Text] [Related]

  • 26. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.
    Heijnen EM, Eijkemans MJ, Hughes EG, Laven JS, Macklon NS, Fauser BC.
    Hum Reprod Update; 2006 Jun; 12(1):13-21. PubMed ID: 16123051
    [Abstract] [Full Text] [Related]

  • 27. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B, Li Z, Zhang H, Jin L, Li Y, Ai J, Zhu G.
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [Abstract] [Full Text] [Related]

  • 28. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K, Gelbaya TA, Laing I, Nardo LG.
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [Abstract] [Full Text] [Related]

  • 29. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T, Ellenbogen A, Michaeli M, Kartchovsky E, Ruzov O, Shalom-Paz E.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [Abstract] [Full Text] [Related]

  • 30. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H, Tonch N, Simons AH, van der Veen F, Hoek A, Land JA.
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [Abstract] [Full Text] [Related]

  • 31. Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes?
    Pereira N, Amrane S, Estes JL, Lekovich JP, Elias RT, Chung PH, Rosenwaks Z.
    Fertil Steril; 2016 Feb; 105(2):539-44.e1. PubMed ID: 26604066
    [Abstract] [Full Text] [Related]

  • 32. Endometriosis and cumulative live birth rate after fresh and frozen IVF cycles with single embryo transfer in young women: no impact beyond reduced ovarian sensitivity-a case control study.
    Feichtinger M, Nordenhök E, Olofsson JI, Hadziosmanovic N, Rodriguez-Wallberg KA.
    J Assist Reprod Genet; 2019 Aug; 36(8):1649-1656. PubMed ID: 31313013
    [Abstract] [Full Text] [Related]

  • 33. Minimal stimulation IVF vs conventional IVF: a randomized controlled trial.
    Zhang JJ, Merhi Z, Yang M, Bodri D, Chavez-Badiola A, Repping S, van Wely M.
    Am J Obstet Gynecol; 2016 Jan; 214(1):96.e1-8. PubMed ID: 26259908
    [Abstract] [Full Text] [Related]

  • 34. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N, Kelly AG, Stone LD, Witzke JD, Lekovich JP, Elias RT, Schattman GL, Rosenwaks Z.
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [Abstract] [Full Text] [Related]

  • 35. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China.
    Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z.
    Hum Reprod; 2013 Oct; 28(10):2728-34. PubMed ID: 23887075
    [Abstract] [Full Text] [Related]

  • 36. [Factors related to occurrence of twin pregnancy after double-embryo transfer in vitro fertilization cycles].
    Niu ZH, Feng Y, Zhang AJ, Zhang HQ, Sun YJ, Lu XW.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):413-7. PubMed ID: 19953939
    [Abstract] [Full Text] [Related]

  • 37. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy.
    Lin YJ, Ou YC, Huang FJ, Lin PY, Kung FT, Lan KC.
    J Minim Invasive Gynecol; 2013 Jun; 20(5):637-41. PubMed ID: 23706676
    [Abstract] [Full Text] [Related]

  • 38. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
    Garcia-Velasco JA, Domingo J, Cobo A, Martínez M, Carmona L, Pellicer A.
    Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
    [Abstract] [Full Text] [Related]

  • 39. Slightly lower incidence of ectopic pregnancies in frozen embryo transfer cycles versus fresh in vitro fertilization-embryo transfer cycles: a retrospective cohort study.
    Decleer W, Osmanagaoglu K, Meganck G, Devroey P.
    Fertil Steril; 2014 Jan; 101(1):162-5. PubMed ID: 24238273
    [Abstract] [Full Text] [Related]

  • 40. Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response.
    Zhang J, Du M, Li Z, Liu W, Ren B, Zhang Y, Guan Y.
    Front Endocrinol (Lausanne); 2021 Jan; 12():708704. PubMed ID: 34630325
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.